Goldman Sachs Cuts Myriad Genetics To Sell, Ups Alere

By: via Benzinga
Myriad Genetics, Inc. (NASDAQ: MYGN) will face mounting evidence in the first-quarter earnings season of dwindling market share and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.